Lack of Evidence for a Role of HHV-6 in the Pathogenesis of Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 49, Issue 1, 2015, Pages 229-235

  Agostini, Simone ^a   Mancuso, Roberta ^a   Baglio, Francesca ^a   Cabinio, Monia ^a   Hernis, Ambra ^a   Guerini, Franca Rosa ^a   Calabrese, Elena ^a   Nemni, Raffaello ^a,b   Clerici, Mario ^a,b  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer's disease; HHV 6; humoral immunity; magnetic resonance imaging

Indexed keywords

HERPES SIMPLEX VIRUS 1 ANTIBODY; HUMAN HERPESVIRUS 6 ANTIBODY; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; VIRUS ANTIBODY; ANTIBODY;

AGED; ALZHEIMER DISEASE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BRAIN REGION; BRAIN SIZE; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLORATORY RESEARCH; FEMALE; HUMAN; HUMAN HERPESVIRUS 6; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; SEROPREVALENCE; VIRUS IMMUNITY; VIRUS LOAD; VIRUS PATHOGENESIS; BLOOD; CASE CONTROL STUDY; EPIDEMIOLOGY; HERPES SIMPLEX VIRUS 1; IMMUNOLOGY; PATHOLOGY; TEMPORAL LOBE; VERY ELDERLY; VIROLOGY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIBODIES; CASE-CONTROL STUDIES; FEMALE; HERPESVIRUS 1, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNITY, HUMORAL; MAGNETIC RESONANCE IMAGING; MALE; MILD COGNITIVE IMPAIRMENT; SEROEPIDEMIOLOGIC STUDIES; TEMPORAL LOBE;

EID: 84948659795     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150464     Document Type: Article

References (36)

1. Petersen RC (2004) Mild cognitive impairment as diagnostic entity. J Intern Med 256, 183-194.
2. Agostini S, Clerici M, Mancuso R (2014) How plausible is a link between HSV-1 infection and Alzheimer's disease Expert Rev Anti Infect Ther 12, 275-278.
3. Itzhaki RF (2014) Herpes simplex virus type 1 and Alzheimer's disease: Increasing evidence for major role of the virus. Front Aging Neurosci 6, 202.
4. Ball MJ (1982) Limbic predilection in Alzheimer dementia: Is reactivated herpesvirus involved Can J Neurol Sci 9, 303-306.
5. Mancuso R, Baglio F, Cabinio M, Calabrese E, Hernis A, Nemni R, Clerici M(2014) Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volume in Alzheimer's disease. J Alzheimers Dis 38, 741-745.
6. Mancuso R, Baglio F, Agostini S, Cabinio M, Laganà MM, Hernis A, Margaritella N, Guerini FR, Zanzottera M, Nemni R, Clerici M (2014) Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer's disease and amnestic mild cognitive impairment. Front Aging Neurosci 6, 285.
7. Gordon L, McQuaid S, Cosby SL (1996) Detection of herpes simplex virus (type 1 and 2) and human herpes virus 6DNAin human brain tissue by polymerase chain reaction. J Neurovirol 6, 33-40.
8. Yoshikawa T, Asano Y (2000) Central nervous system complications in human herpesvirus-6 infection. Brain Dev 22, 307-314.
9. Lin WR, Wozniak MA, Wilcock GK, Itzhaki RF (2002) Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients. Neirobiol Dis 9, 82-87.
10. Wozniak MA, Shipley SJ, Combrinck M, Wilcock GK, Itzhaki RF (2005) Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patiens. J Med Virol 75, 300-306.
11. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement 7, 263-269.
12. Morris JC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43, 2412-2414.
13. Magni E, Binetti G, Bianchetti A, Rozzini R, Trabucchi M (1996) Mini-Mental State Examination: A normative study in Italian elderly population. Eur J Neurol 3, 198-202.
14. Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ, Alzheimer's Disease Cooperative Study (2004) Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 61, 59-66.
15. Rosen WJ, Terry RD, Fuld PA, Katzman R, Peck A (1980) Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 7, 486-488.
16. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23, 56-62.
17. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53, 695-699.
18. Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes Muller-Hermelink HK, Steinmann GG (1984) Admission criteria for immunogerontological studies in man: The SENIEUR protocol. Mech Ageing Dev 28, 47-55.
19. Ashburner J, Friston KJ (2005) Unified segmentation. Neuroimage 26, 839-851.
20. Honjo K, van Reekum R, Verhoeff NP (2009) Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease Alzheimers Dement 5, 348-360.
21. Carvey PM, Hendey B, Monahan AJ (2009) The blood-brain barrier in neurodegenerative disease:Arhetorical perspective. J Neurochem 111, 291-314.
22. Burgmans S, va de Haar HJ, Verhey FR, Backes WH (2013) Amyloid-beta interacts with blood-brain barrier function in dementia: A systematic review. J Alzheimers Dis 35, 859-873.
23. Leibovitch E, Jacobson S (2014) Evidence linking HHV-6 with multiple sclerosis: An update. Curr Opin Virol 9, 127-133.
24. Luppi M, Barozzi P, Maiorana A, Marasca R, Torelli G(1994) Human herpesvirus 6 infection in normal human brain tissue. J Infect Dis 169, 943-944.
25. Carbone I, Lazzarotto T, Ianni M, Porcellini E, Forti P, Masliah E, Gabrielli L, Licastro F (2013) Herpes virus in Alzheimer's disease: Relation to progression of the disease. Neurobiol Aging 35, 122-129.
26. Licastro F, Raschi E, Carbone I, Porcellini E (2015) Variants in antiviral genes are risk factors for cognitive decline and dementia. J Alzheimers Dis 46, 655-663.
27. Soderberg-Naucler C, Nelson JY (1999) Human cytomegalovirus latency and reactivation-a delicate balance between the virus and its host's immune system. Intervirology 42, 314-321.
28. Stowe RP, Kozlova EV, Yetman DL, Walling DM, Goodwin JS, Glaser R (2007) Chronic herpesvirus reactivation occurs in aging. Exp Gerontol 42, 563-570.
29. Koch S, Solana R, Dela RO, Pawelec G (2006) Human cytomegalovirus infection and T cell immunosenescence: A mini review. Mech Ageing Dev 127, 538-543.
30. Lin WR, Wozniak MA, Cooper RJ, Wilcock GK, Itzhaki RF (2002) Herpesviruses in brain and Alzheimer's disease. J Pathol 197, 395-402.
31. Strandberg TE, Pitkala KH, Linnavuori K, Tilvis RS (2004) Cognitive impairment and infectious burden in the elderly. Arch Gerontol Geriatr Suppl 9, 419-423.
32. Aiello AE, Haan M, Blythe L, Moore K, Gonzales JM, Jagust W (2006) The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc 54, 1046-1054.
33. Mathei C, Vaes B, Wallemacq P, Degryse J (2011) Association between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL Cohort. J Am Geriatr Soc 59, 2201-2208.
34. Gow AJ, Firth CM, Harrison R, Starr JM, Moss P, Deary IJ (2013) Cytomegalovirus infection and cognitive abilities in old age. Neurobiol Aging 34, 1846-1852.
35. Tarter KD, Simanek AM, Dowd JB, Aiello AE (2014) Persistent viral pathogens and cognitive impairment across the lifecourse in the third National health and nutrion examination survey. J Infect Dis 209, 837-844.
36. Barnes LL, Capuano AW, Aiello AE, Turner AD, Yolken RH, Fuller Torrey E, Bennett DA (2015) Cytomegalovirs infection and risk of Alzheimer disease in older black and white individuals. J Infect Dis 211, 230-237.